Switzerland discovers new drug to treat Alzheimer's disease

Scientists at the University of Lausanne, Switzerland, have discovered a new treatment for Alzheimer's disease, attacking the cause of the world's most common memory loss.

A new generation of anti-Alzheimer's drugs is said to be promising after scientists at the École Polytechnique Fédérale deciphered how two molecules work, which they have been testing for three years in the laboratory and on patient volunteers.

Illustration photo. (Source: aircrap.org)

Scientists believe that the above-mentioned molecules directly attack the cause of Alzheimer's disease and do not cause side effects. This new drug has the ability to stop the development of the disease but cannot restore the activity of neurons that have been destroyed before.

In people with Alzheimer's disease, the buildup of organic molecules, amyloid plaques, forms toxic plaques that destroy surrounding neurons.

According to this new drug, a protein called "APP" will penetrate the neuronal membrane, with the help of an enzyme, APP will break into many small pieces and produce shorter amyloid peptides, which cannot aggregate into toxic neuronal plaques.

The research results are said to be very promising for a new, very effective drug against a disease that has so far had no successful treatment. Once the full research results are available, manufacturers will continue to take all measures to ensure a safe drug product, a process that will take time.

It is expected that this drug will be on the market in about 5 to 10 years.

Alzheimer's disease appeared more than 100 years ago, but it is only in the last 20 years that scientists have researched drugs to treat this disease./.

According to (TTXVN) - VT